Renovis Surgical Receives FDA clearance

Renovis Surgical Receives FDA clearance
Renovis Surgical Receives FDA clearance

Renovis Surgical Technologies, Inc. has recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Tesera™ SC – Porous Titanium Cervical Interbody Fusion System.

Tesera SC is a porous titanium stand-alone cervical interbody fusion system featuring a three-screw design and a locking cover plate to prevent screw backout. Implants are available in two lordotic angles with varying heights and footprints for proper intervertebral height restoration, along with advanced instrumentation designed to reduce operative steps. All Tesera implants utilize additive manufacturing (3D printing) and a patent-pending design to create a highly porous surface structure that allows for bone ingrowth to the implant surfaces, maximizing strength, stability and biologic fixation.